Chinook Therapeutics Inc (NASDAQ:KDNY)
| 22.16 BATS BZX Real-Time Price As of 11:11am ET |  +0.60 / +2.76%Today’s Change | 12.41 Today|||52-Week Range 27.44 | -15.44% Year-to-Date |
Latest KDNY News | Press Releases
No recent news for Chinook Therapeutics Inc.
Today’s Trading
| Previous close | 21.56 |
| Today’s open | 21.86 |
| Day’s range | 21.86 - 22.21 |
| Volume | 8,529 |
| Average volume (3 months) | 557,971 |
| Market cap | $1.5B |
Data as of 11:11am ET, 03/23/2023
Growth & Valuation
| Earnings growth (last year) | -29.31% |
| Earnings growth (this year) | -10.43% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -88.13% |
| P/E ratio | NM |
| Price/Sales | 275.21 |
| Price/Book | 3.30 |
Competitors
Data as of 11:10am ET, 03/23/2023
Financials
| Next reporting date | May 11, 2023 |
| EPS forecast (this quarter) | -$0.80 |
| Annual revenue (last year) | $6.1M |
| Annual profit (last year) | -$187.9M |
| Net profit margin | -3,065.68% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Seattle, Washington |
Forecasts
